Acute treatment of migraine: quo vadis?
Author:
Affiliation:
1. Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1329821
Reference21 articles.
1. Chronic migraine treatment: from OnabotulinumtoxinA onwards
2. Emerging drugs for migraine treatment
3. Anti-CGRP monoclonal antibodies in migraine: current perspectives
4. Lasmiditan for the treatment of migraine
5. New strategies for the treatment and prevention of primary headache disorders
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The spray-dried mucoadhesive microparticles of rizatriptan with chitosan and carbopol in migraine;Egyptian Pharmaceutical Journal;2022
2. Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor*;Journal of Pharmacology and Experimental Therapeutics;2020-01-28
3. Single Therapeutic and Supratherapeutic Doses of Ubrogepant Do Not Affect Cardiac Repolarization in Healthy Adults: Results From a Randomized Trial;Clinical Pharmacology & Therapeutics;2019-12-14
4. Advances in orally administered pharmacotherapy for the treatment of migraine;Expert Opinion on Pharmacotherapy;2018-11-26
5. Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial;The Journal of Headache and Pain;2018-10-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3